Australian medicinal cannabis firm Cann has moved quickly to maximise the benefits of its CBD Gelpell capsule technology by entering into a collaboration deal with healthcare technology firm Emyria
Written by Lorraine Mullaney || 21st April 2021 || News analysis | Companies | Health and science | Technology and innovation | Australasia Australia